87A.F · American Renal Associates Holdings, Inc

-

Please sign in to comment on 87A.F

1 Comment

Admin

4 years ago

American Renal Associates Holdings, Inc is currently in a long term uptrend where the price is trading 22.9% above its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.

American Renal Associates Holdings, Inc's total revenue sank by 0.8% to $210M since the same quarter in the previous year.

Its net income has dropped by 156.3% to $-3M since the same quarter in the previous year.

Finally, its free cash flow fell by 34.7% to $15M since the same quarter in the previous year.

Based on the above factors, American Renal Associates Holdings, Inc gets an overall score of 2/5.

Exchange	F
ISIN	None
Sector	Healthcare
Industry	Health Information Services
CurrencyCode	EUR

Market Cap	328M
PE Ratio	None
Target Price	None
Dividend Yield	13.%
Beta	1.11

ABOUT

American Renal Associates Holdings, Inc

Spotlite360 Technologies, Inc. operates as a software as a service (SaaS) company. It offers Spotlite360, a SaaS-based supply chain execution, tracing, tracking, and sustainability platform to enterprise customers in the pharmaceutical, healthcare, and agricultural industries. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.

87A.F · American Renal Associates Holdings, Inc

-

American Renal Associates Holdings, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest American Renal Associates Holdings, Inc using a moving average strategy